AcelRx Pharmaceuticals Inc (ACRX)
Market Closed
16 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 92
+0.04
+4.0551%
$
14.58M Market Cap
- P/E Ratio
- Div Yield
172,804 Volume
-1.18 Eps
$ 0.89
Previous Close Analysts:
Want to track ACRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AcelRx Pharmaceuticals Inc (ACRX) Statistics
Valuation metrics
Market Cap 14.58M
Enterprise value 14.1M
Trailing P/E (ttm) -2.6
Forward P/E -
PEG ratio -0.12
Price/Sales (ttm) 17,919.21
Price/Book (mrq) 2
Enterprise Value/Revenue 14,096.21
Enterprise Value/EBITDA -0.9
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 143.45K
Average volume (90 days) 157.77K
Price summary
52-Week low 0.38
52-Week high 1.57
Beta -
50-Day moving average 0.83
200-Day moving average 0.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 26 Oct 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -14,253%
Operating margin -14,516%
Operational effectiveness
Return on assets -0.47%
Return on equity -0.93%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.5
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 5.3%
Book value per share (mrq) 0.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
